Mylan Pharmaceuticals Inc. recalls Loxapine Capsules, USP 50 mg, Rx Only, 100-count bottles, NDC 0378-7050-01
Recalled May 30, 2018 · FDA recall D-0825-2018 · Mylan Pharmaceuticals
Hazard
CGMP Deviations · FDA Class II
Units
11,650 bottles
Sold at
Product was distributed throughout the United States, including Puerto Rico.
Description
CGMP Deviations
Product
Loxapine Capsules, USP 50 mg, Rx Only, 100-count bottles, NDC 0378-7050-01
Manufacturer(s)
Mylan Pharmaceuticals Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →